Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bala Cynwyd, Pennsylvania
- Most recent report
- 8-K, filed Sep 29, 2026
- Incorporated
- Delaware
- Filings on record
- 694 filings
- On EDGAR
- CIK 1374690
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 50
News 8 of 152
Prospectuses and Registrations 8 of 44
- S-8 Registration statement for an employee plan Mar 19, 2026
- 424B5 Prospectus supplement for an offering Feb 26, 2026
- 424B5 Prospectus supplement for an offering Feb 25, 2026
- 424B5 Prospectus supplement for an offering Jul 31, 2025
- 424B5 Prospectus supplement for an offering Jul 29, 2025
- S-8 Registration statement for an employee plan Mar 24, 2025
- S-3 Shelf registration statement May 9, 2024
- S-8 Registration statement for an employee plan Mar 14, 2024
Proxies 8 of 23
- DEF 14A Proxy statement for a shareholder vote Apr 20, 2026
- PRE 14A Preliminary proxy statement Apr 10, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 11, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- PRE 14A Preliminary proxy statement Apr 12, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 11, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 12, 2022
- DEF 14A Proxy statement for a shareholder vote Apr 14, 2021
Ownership 8 of 372
- 4 Insider reported a trade Jul 8, 2026
- 4 Insider reported a trade May 20, 2026
- 4 Insider reported a trade May 20, 2026
- 4 Insider reported a trade May 20, 2026
- 4 Insider reported a trade May 20, 2026
- 4 Insider reported a trade May 20, 2026
- 4 Insider reported a trade May 20, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 14, 2026
Other 8 of 53
- ARS Annual report sent to shareholders Apr 20, 2026
- ARS Annual report sent to shareholders Apr 11, 2025
- EFFECT Notice that a registration became effective May 24, 2024
- CORRESP Reply to SEC staff May 22, 2024
- UPLOAD Comment letter from SEC staff May 16, 2024
- ARS Annual report sent to shareholders Apr 29, 2024
- ARS Annual report sent to shareholders Apr 11, 2023
- EFFECT Notice that a registration became effective Nov 21, 2022
Everything here comes from Larimar Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.